Offshore
Photo
โ Dimitry Nakhla | Babylon Capitalยฎ
A sober valuation analysis on $PYPL ๐Ÿง˜๐Ÿฝโ€โ™‚๏ธ

โ€ขNTM P/E Ratio: 18.47x
โ€ขAll-Time Mean: 29.55x

โ€ขNTM FCF Yield: 7.42%
โ€ขAll-Time Mean: 5.07%

As you can see, $PYPL appears to be trading below fair value

Going forward, investors can receive ~53% MORE in earnings per share & ~46% MORE in FCF per share ๐Ÿง ***

Before we get into valuation, letโ€™s take a look at why $PYPL is a good business

BALANCE SHEETโœ…
โ€ขCash & Short-Term Inv: $11.92B
โ€ขLong-Term Debt: $9.98B

$PYPL has an excellent balance sheet, an A- S&P Credit Rating, & 20x FFO Interest Coverage

RETURN ON CAPITALโœ…
โ€ข2019: 12.4%
โ€ข2020: 11.5%
โ€ข2021: 13.6%
โ€ข2022: 12.7%
โ€ข2023: 14.8%
โ€ขLTM: 16.6%

RETURN ON EQUITYโœ…
โ€ข2019: 15.2%
โ€ข2020: 22.7%
โ€ข2021: 20.0%
โ€ข2022: 11.5%
โ€ข2023: 20.5%
โ€ขLTM: 22.2%

$PYPL has strong return metrics, highlighting the financial efficiency of the business

REVENUESโœ…
โ€ข2018: $15.45B
โ€ข2023: $29.77B
โ€ขCAGR: 14.01%

FREE CASH FLOWโŒ*
โ€ข2018: $4.66B
โ€ข2023: $4.22B
โ€ขDecrease: (9.44%)

*LTM FCF is $7.05B ๐Ÿ“ˆ

*Also, FCF in 2017 was $1.86B, so FCF rose ~150% in 2018 start date (โ€œnormalizingโ€ the decline above)

NORMALIZED EPSโœ…
โ€ข2018: $2.42
โ€ข2023: $5.10
โ€ขCAGR: 16.07%

SHARE BUYBACKSโœ…
โ€ข2018 Shares Outstanding: 1.20B
โ€ขLTM Shares Outstanding: 1.06B

By reducing its shares outstanding by 11.6%, $PYPL increased its EPS by 13.1% (assuming 0 growth)

MARGINSโœ…
โ€ขLTM Gross Margins: 40.1%
โ€ขLTM Operating Margins: 17.7%
โ€ขLTM Net Income Margins: 14.1%

***NOW TO VALUATION ๐Ÿง 

As stated above, investors can expect to receive ~53% MORE in EPS & ~46% MORE in FCF per share

Using Benjamin Grahamโ€™s 2G rule of thumb, $PYPL has to grow earnings at a 9.29% CAGR over the next several years to justify its valuation

Today, analysts anticipate 2025 - 2027 EPS growth over the next few years to be greater than the (9.29%) required growth rate:

2024E: $4.57 (-10.3% YoY) *FY Dec

2025E: $4.89 (6.9% YoY)
2026E: $5.43 (11.1% YoY)
2027E: $6.37 (17.3% YoY)

$PYPL has an ok track record of meeting analyst estimates ~2 years out, but letโ€™s assume $PYPL ends 2027 with $6.37 in EPS & see its CAGR potential assuming different multiples

21x P/E: $133.77๐Ÿ’ต โ€ฆ ~14.3% CAGR

20x P/E: $127.40๐Ÿ’ต โ€ฆ ~12.5% CAGR

19x P/E: $121.03๐Ÿ’ต โ€ฆ ~10.6% CAGR

18x P/E: $114.66๐Ÿ’ต โ€ฆ ~8.7% CAGR

As you can see, $PYPL appears to have attractive return potential if we assume >19x earnings & aggressive return potential if we assume >20x earnings

The ๐Ÿ”‘ isn't a mean reversion in $PYPL's multiple, but a modest increase (still below its historical average) - a reasonable and safe assumption

Everyone wanted $PYPL when it traded 50x earnings, not many wanted it when it traded for 12x earnings โ˜ฏ๏ธ

Thereโ€™s STILL negative sentiment around $PYPL and this sentiment is already being changed as management continues to make good progress

Today at $88.50๐Ÿ’ต $PYPL still appears to be a good consideration for investment (albeit, with some turnaround / competitive risks & a smaller margin of safety)

#stocks #investing
___

๐ƒ๐ˆ๐’๐‚๐‹๐Ž๐’๐”๐‘๐„โ€ผ๏ธ: ๐“๐ก๐ข๐ฌ ๐ข๐ฌ ๐๐Ž๐“ ๐ˆ๐ง๐ฏ๐ž๐ฌ๐ญ๐ฆ๐ž๐ง๐ญ ๐€๐๐ฏ๐ข๐œ๐ž. ๐๐š๐›๐ฒ๐ฅ๐จ๐ง ๐‚๐š๐ฉ๐ข๐ญ๐š๐ฅยฎ ๐š๐ง๐ ๐ข๐ญ๐ฌ ๐ซ๐ž๐ฉ๐ซ๐ž๐ฌ๐ž๐ง๐ญ๐š๐ญ๐ข๐ฏ๐ž๐ฌ ๐ฆ๐š๐ฒ ๐ก๐š๐ฏ๐ž ๐ฉ๐จ๐ฌ๐ข๐ญ๐ข๐จ๐ง๐ฌ ๐ข๐ง ๐ญ๐ก๐ž ๐ฌ๐ž๐œ๐ฎ๐ซ๐ข๐ญ๐ข๐ž๐ฌ ๐๐ข๐ฌ๐œ๐ฎ๐ฌ๐ฌ๐ž๐ ๐ข๐ง ๐ญ๐ก๐ข๐ฌ ๐ญ๐ฐ๐ž๐ž๐ญ.

๐“๐ก๐ž ๐ข๐ง๐Ÿ๐จ๐ซ๐ฆ๐š๐ญ๐ข๐จ๐ง ๐œ๐จ๐ง๐ญ๐š๐ข๐ง๐ž๐ ๐ข๐ง ๐ญ๐ก๐ข๐ฌ ๐ญ๐ฐ๐ž๐ž๐ญ ๐ข๐ฌ ๐ข๐ง๐ญ๐ž๐ง๐๐ž๐ ๐Ÿ๐จ๐ซ ๐ข๐ง๐Ÿ๐จ๐ซ๐ฆ๐š๐ญ๐ข๐จ๐ง๐š๐ฅ ๐ฉ๐ฎ๐ซ๐ฉ๐จ๐ฌ๐ž๐ฌ ๐จ๐ง๐ฅ๐ฒ ๐š๐ง๐ ๐ฌ๐ก๐จ๐ฎ๐ฅ๐ ๐ง๐จ๐ญ ๐›๐ž ๐œ๐จ๐ง๐ฌ๐ญ๐ซ๐ฎ๐ž๐ ๐š๐ฌ ๐ข๐ง๐ฏ๐ž๐ฌ๐ญ๐ฆ๐ž๐ง๐ญ ๐š๐๐ฏ๐ข๐œ๐ž ๐ญ๐จ ๐ฆ๐ž๐ž๐ญ ๐ญ๐ก๐ž ๐ฌ๐ฉ๐ž๐œ๐ข๐Ÿ๐ข๐œ ๐ง๐ž๐ž๐๐ฌ ๐จ๐Ÿ ๐š๐ง๐ฒ ๐ข๐ง๐๐ข๐ฏ๐ข๐๐ฎ๐š๐ฅ ๐จ๐ซ ๐ฌ๐ข๐ญ๐ฎ๐š๐ญ๐ข๐จ๐ง. ๐๐š๐ฌ๐ญ ๐ฉ๐ž๐ซ๐Ÿ๐จ๐ซ๐ฆ๐š๐ง๐œ๐ž ๐ข๐ฌ ๐ง๐จ ๐ ๐ฎ๐š๐ซ๐š๐ง๐ญ๐ž๐ž ๐จ๐Ÿ ๐Ÿ๐ฎ๐ญ๐ฎ๐ซ๐ž ๐ซ๐ž๐ฌ๐ฎ๐ฅ๐ญ๐ฌ.

๐ˆ๐ง๐Ÿ๐จ๐ซ๐ฆ๐š๐ญ๐ข๐จ๐ง ๐œ๐จ๐ง๐ญ๐š๐ข๐ง๐ž๐ ๐ข๐ง ๐ญ๐ก๐ข๐ฌ ๐ญ๐ฐ๐ž๐ž๐ญ ๐ก๐š๐ฌ ๐›๐ž๐ž๐ง ๐จ๐›๐ญ๐š๐ข๐ง๐ž๐ ๐Ÿ๐ซ๐จ๐ฆ ๐ฌ๐จ๐ฎ๐ซ๐œ๐ž๐ฌ ๐›๐ž๐ฅ๐ข๐ž๐ฏ๐ž๐ ๐ญ๐จ ๐›๐ž ๐ซ๐ž๐ฅ๐ข๐š๐›๐ฅ๐ž, ๐›๐ฎ๐ญ ๐ข๐ฌ ๐ง๐จ๐ญ ๐ ๐ฎ๐š๐ซ๐š๐ง๐ญ๐ž๐ž๐ ๐š๐ฌ ๐ญ๐จ ๐œ๐จ๐ฆ๐ฉ๐ฅ๐ž๐ญ๐ž๐ง๐ž๐ฌ๐ฌ ๐จ๐ซ ๐š๐œ๐œ๐ฎ๐ซ๐š๐œ๐ฒ.
tweet
Offshore
Photo
โ Quiver Quantitative
JUST IN: Representative Marjorie Taylor Greene has disclosed a purchase of AbbVie stock, $ABBV.

The purchase was made on Wednesday.

The pharma stock has risen 5% since then. https://t.co/6dtz4mO5Jm
tweet
โ Quiver Quantitative
RT @InsiderRadar: All of these stocks are in the green this morning as well

$ARRY: +8.15%
$ENPH: +7.87%
$ONEW: +5.01%
$EL: +4.96%
$TRS: +0.93%

We reported on 5 new significant insider purchases this week.

So far, each stock has beaten the market since our report:

$250K purchase of $TRS by CEO on 11/19. Since our report, the stock is up 5.5%.

$10M purchase of $EL by director on 11/19. Since our report, the stock is up 8.8%.

$100K purchase of $ARRY by CEO on 11/20. Since our report, the stock is up 5.5%.

$300K purchase of $ENPH by CEO on 11/20. Since our report, the stock is up 5.0%.

$450K purchase of $ONEW by CEO on 11/21. Since our report, the stock is up 6.0%.
- Insider Radar
tweet
Offshore
Photo
โ Stock Analysis Compilation
TCW on Elevance Health $ELV US

Thesis: Elevance Healthโ€™s strong leadership, innovative services, and expansion opportunities in the healthcare market provide a solid foundation for growth and increased earnings

(Extract from their Q3 letter) https://t.co/APbDb0AXu2
tweet
Offshore
Video
โ Startup Archive
Peter Thiel on the type of company more startup founders should build

Thiel first emphasizes his belief that when starting a company, you should always ask:

โ€œCan this company become a monopoly?โ€

He then lists three of the most common types of monopolies:

1. Super fast distribution on a very thin product (e.g. Twitter)

2. A technological advantage that is continually built upon with iterative improvement and compounds over time (e.g. SaaS software)

3. A truly brilliant breakthrough (e.g. Bitcoin)

But he argues that thereโ€™s a different monopoly category thatโ€™s continually overlooked:

โ€œA different modality for innovation that we do very little of and we donโ€™t even recognize as an important category is what I would describe as โ€˜Complex Coordination,โ€™ where you take a lot of different pieces and the challenge is to coordinate them into something new.โ€

Thiel continues:

โ€œThis is the thing thatโ€™s maybe 180 degrees antithetical to the Lean Startup ethos. Itโ€™s complicated. You have to put all the pieces together in just the right way. I think this is on some level what really drove Apple as an innovative company in the last decadeโ€ฆ What was new about the iPhone? There was no single component that was new. It was just that you put all of these things together in just the right wayโ€ฆ and once you built it, it was actually super hard for people to replicate. You had an advantage for many years.โ€

He points to Tesla and SpaceX as more recent examples.

โ€œThereโ€™s no component to the Tesla thatโ€™s actually that new. Itโ€™s just that you put all of the pieces together. You re-engineered the whole distributor network. It was this complex coordination that made it work. Thereโ€™s like this lost art of accounting where you figure out how much things cost and add them all together. And Elon has discovered this lost art of accounting which no other people practice.โ€

Video source: @GA (2015)
tweet
Offshore
Photo
โ Stock Analysis Compilation
Miller Value on Gannett $GCI US

Thesis: Gannettโ€™s digital transformation, legal upside potential, and deep undervaluation offer a compelling opportunity for substantial re-rating and market cap growth.

(Extract from their Q3 letter) https://t.co/RLEXCaKsUQ
tweet
Offshore
Photo
โ Dimitry Nakhla | Babylon Capitalยฎ
RT @DimitryNakhla: $ASML currently trading at the lower end of its historical valuation range, despite maintaining robust growth prospects & a wide moat ๐Ÿ’ธ

#stocks #investing https://t.co/NPRouhc09g
tweet
Offshore
Photo
โ Quiver Quantitative
Another one.

We posted this report on a suspicious purchase of Perella Weinberg stock by a U.S. Congressman in April.

$PWP has now risen 93% since the trade. https://t.co/dYQxFiaGFk
tweet
Offshore
Photo
โ App Economy Insights
$ZM Zoom Q3 FY25 (October quarter).

โ€ข Enterprise DBNE 98% TTM (unchanged).
โ€ข Customers > $100K TTM +7% Y/Y to 4K.
โ€ข Revenue +3% Y/Y to $1,178M ($10M beat).
โ€ข Non-GAAP EPS $1.38 ($0.07 beat).
โ€ข FY25 Guidance ~$4.66B ($20M beat). https://t.co/aPfR1IO1O6
tweet
โ Quiver Quantitative
RT @InsiderRadar: $IMNM stock rose 13.5% today, following these pre-market insider purchases

๐Ÿšจ JUST IN: 3 New Insider Purchases at $IMNM

- $960K purchase by CEO
- $150K purchase by Chief Medical Officer
- $200K purchase by CTO

All three of these trades were filed this morning, shortly before market open.
- Insider Radar
tweet
โ Quiver Quantitative
RT @InsiderRadar: ๐Ÿšจ JUST IN: New CFO Insider Purchase

The CFO of $PRKS has reported the purchase of ~$1.9M of the company's stock.

This is his first reported insider trade, and comes just a month after he was appointed CFO.
tweet